Abstract:Introduction Atherosclerotic cardiovascular disease is the leading cause of death in the United States. Intimal macrophages are determinant cells in the atherosclerotic lesion formation by facilitating cholesterol accumulation and increasing the inflammatory response in blood vessel walls. T0901317 can prevent and dramatically regress atherosclerosis by increasing cholesterol efflux and inhibiting inflammatory response via activating macrophage liver X receptors (LXR) . However its side effects including hypertriglyceridemia and hepatic steatosis hinder its application in clinics. We have successfully made T0901317 encapsulated nanovesicles (Tnano) and ligand‐incorporated Tnano (LTnano). Nanovesicles without T0901317 is Vnano, ligand Vnano is LVnano. This target ligand has a high binding affinity to macrophage scavenger receptor CD36. The object of the project is to investigate the anti‐atherogenic effect of LTnano in macrophages. Methods We used THP‐1 derived macrophages in this study. CD36 siRNA and Lipofectamine® RNAiMAX Transfection Reagent were used to knock down the CD36 in these macrophages. Scrambled SiRNA were used as a control. Fluorescence 1‐Oleoyl‐2‐[12‐[(7‐nitro‐2‐1,3‐benzoxadiazol‐4‐yl)amino]dodecanoyl]‐sn‐Glycero‐3‐Phosphocholine (NBD) were used to label all nanovesicles. THP‐1 derived macrophages and CD36 knockdown macrophages were treated with NBD‐labeled nanovesicles at 37 °C for 2 hours. After washing, cell nuclei were stained with 4′,6‐diamidino‐2‐phenylindole dihydrochloride (DAPI). Macrophage binding and uptake of nanovesicles were observed under an EVOS® fluorescence microscope. To investigate the cholesterol lowering effect, THP‐1 derived macrophages were treated with Tnano, LTnano, free T0901317 at 1μM and controls (Vnano, LVnano, PBS). Total cholesterol and free cholesterol were measured using a HPLC method. Cholesterol ester was calculated as the difference between total and free cholesterol. Gene expression of scavenger receptors and some cytokines were measured using real time PCR. Results LTnano had a higher binding affinity to macrophages than Tnano. CD36 knockdown diminished LTnano binding to and uptake by macrophages. LTnano also decreased macrophage total and free cholesterol content compare to free T0901317 or Tnano. LTnano increased the mRNA levels of ATP Binding Cassette Subfamily A Member 1 and ATP‐binding cassette sub‐family G member 1 . Expression of LXR, tumor necrosis factor alpha, monocyte chemoattractant protein‐1, and interleukin 6, macrophage scavenger receptor 1, scavenger receptor class B member 1, CD36 will be determined. Conclusions LTnano targeted macrophages via their CD36 binding sites. LTnano decreased macrophage total and free cholesterol content, which correlated with increased expression of ABCA1 and ABCG1. Additional anti‐atherogenic mechanisms are under investigation. Support or Funding Information Grant Funding Source: NIH 1R15AT007013‐01

Studies on LDTI Inhibiting the Specific Activity of Tryptase and Blocking Its Function to Inhibit Cholesterol Efflux

The Effect of Lecithins Coupled Decorin Nanoliposomes on Treatment of Carbon Tetrachloride-Induced Liver Fibrosis

Effects of trichostatin A on the expressions of inflammatory cytokines and toll-like receptor 4 and the acetylation of nuclear factor-κB induced by lipopolysaccharide in macrophage

Triterpenoid-Enriched Extract of Ilex Kudingcha Inhibits Aggregated Ldl-Induced Lipid Deposition in Macrophages by Downregulating Low Density Lipoprotein Receptor-Related Protein 1 (Lrp1)

Tryptase promotes human monocyte-derived macrophage foam cell formation by suppressing LXRalpha activation.

The Influence of sTM-LDL on Foam Cells Formation

Diterpenoids inhibit ox-LDL-induced foam cell formation in RAW264.7 cells by promoting ABCA1 mediated cholesterol efflux

[Effect of l-tetrahydropalmatine on expression of adhesion molecules induced by lipopolysaccharides in human umbilical vein endothelium cell].

Inhibition of Toll-like Receptors Alters Macrophage Cholesterol Efflux and Foam Cell Formation

A Peptide Inhibitor of Macrophage Migration in Atherosclerosis Purified from the Leech Whitmania Pigra.

Study on the regulatory effect of leech peptide HE-D on macrophages in atherosclerosis by transcriptome sequencing

Anti‐atherogenic Effect of T0901317 Nanovesicles in THP‐1 Derived Macrophages

Macrophage malfunction in Triptolide-induced indirect hepatotoxicity

Tryptase Promotes Atherosclerotic Plaque Haemorrhage in ApoE-/- Mice

Effects of Tripeptide Tyroserleutide on Phagocytosis and Antitumor Effects of Macrophage

[Study on the Protective Effect of HDL Subclasses Against Lipopolysaccharide].

Terpene Lactucopicrin Limits Macrophage Foam Cell Formation by a Reduction of Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 in Lipid Rafts

Inhibitory effect of triterpenoid saponins from the leaves of Ilex kudingcha on aggregated LDL-induced lipid deposition in macrophages.

Lck Inhibits Heat Shock Protein 65-Mediated Reverse Cholesterol Transport in T Cells

Apelin-13 inhibits lipoprotein lipase expression via the APJ/PKC&agr;/miR-361-5p signaling pathway in THP-1 macrophage-derived foam cells

[Inhibition of Human Macrophage-Derived Foam Cell Differentiation by Blocking Kv1.3 and Kir2.1 Channels].